BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12908826)

  • 1. Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model.
    Peters MG; Farías E; Colombo L; Filmus J; Puricelli L; Bal de Kier Joffé E
    Breast Cancer Res Treat; 2003 Jul; 80(2):221-32. PubMed ID: 12908826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation.
    Stigliano I; Puricelli L; Filmus J; Sogayar MC; Bal de Kier Joffé E; Peters MG
    Breast Cancer Res Treat; 2009 Mar; 114(2):251-62. PubMed ID: 18404367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth-suppressing function of glypican-3 (GPC3) via insulin like growth factor II (IGF-II) signaling pathway in ovarian clear cell carcinoma cells.
    Sakurai M; Shibata K; Umezu T; Kajiyama H; Yamamoto E; Ino K; Nawa A; Kikkawa F
    Gynecol Oncol; 2010 Nov; 119(2):332-6. PubMed ID: 20701957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glypican-3 modulates inhibitory Bmp2-Smad signaling to control renal development in vivo.
    Hartwig S; Hu MC; Cella C; Piscione T; Filmus J; Rosenblum ND
    Mech Dev; 2005 Jul; 122(7-8):928-38. PubMed ID: 15925496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.
    Midorikawa Y; Ishikawa S; Iwanari H; Imamura T; Sakamoto H; Miyazono K; Kodama T; Makuuchi M; Aburatani H
    Int J Cancer; 2003 Feb; 103(4):455-65. PubMed ID: 12478660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells.
    Elliott BE; Meens JA; SenGupta SK; Louvard D; Arpin M
    Breast Cancer Res; 2005; 7(3):R365-73. PubMed ID: 15987432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA; Kittrell FS; Medina D; Butel JS
    Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
    Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
    Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
    Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
    J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells.
    Matsuda K; Maruyama H; Guo F; Kleeff J; Itakura J; Matsumoto Y; Lander AD; Korc M
    Cancer Res; 2001 Jul; 61(14):5562-9. PubMed ID: 11454708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981.
    Che G; Chen J; Liu L; Wang Y; Li L; Qin Y; Zhou Q
    Neoplasma; 2006; 53(6):530-7. PubMed ID: 17167724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.
    Sin S; Bonin F; Petit V; Meseure D; Lallemand F; Bièche I; Bellahcène A; Castronovo V; de Wever O; Gespach C; Lidereau R; Driouch K
    J Natl Cancer Inst; 2011 Sep; 103(17):1323-37. PubMed ID: 21832234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling.
    Chiao E; Fisher P; Crisponi L; Deiana M; Dragatsis I; Schlessinger D; Pilia G; Efstratiadis A
    Dev Biol; 2002 Mar; 243(1):185-206. PubMed ID: 11846487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation in vivo of the invasion-suppressor molecule E-cadherin in experimental and clinical cancer.
    Mareel M; Vleminckx K; Vermeulen S; Yan G; Bracke M; van Roy F
    Princess Takamatsu Symp; 1994; 24():63-80. PubMed ID: 8983064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth promotion of HepG2 hepatoma cells by antisense-mediated knockdown of glypican-3 is independent of insulin-like growth factor 2 signaling.
    Sung YK; Hwang SY; Farooq M; Kim JC; Kim MK
    Exp Mol Med; 2003 Aug; 35(4):257-62. PubMed ID: 14508064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of glypican-3 as a novel tumor marker for melanoma.
    Nakatsura T; Kageshita T; Ito S; Wakamatsu K; Monji M; Ikuta Y; Senju S; Ono T; Nishimura Y
    Clin Cancer Res; 2004 Oct; 10(19):6612-21. PubMed ID: 15475451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant negative inhibition of the association between beta-catenin and c-erbB-2 by N-terminally deleted beta-catenin suppresses the invasion and metastasis of cancer cells.
    Shibata T; Ochiai A; Kanai Y; Akimoto S; Gotoh M; Yasui N; Machinami R; Hirohashi S
    Oncogene; 1996 Sep; 13(5):883-9. PubMed ID: 8806677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glypican-3 expression is silenced in human breast cancer.
    Xiang YY; Ladeda V; Filmus J
    Oncogene; 2001 Nov; 20(50):7408-12. PubMed ID: 11704870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
    Fujimoto K; Sheng H; Shao J; Beauchamp RD
    Exp Cell Res; 2001 Jun; 266(2):239-49. PubMed ID: 11399052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.